Skip to content

MDA Dicamba Herbicide 2021 Labels and Cutoff Date Info

The Minnesota Department of Agriculture (MDA) previously announced a June 30 cutoff date for dicamba applications to dicamba tolerant soybeans for 2021 (MDA Announces June 30 Cutoff Date of Dicamba Herbicide for 2021).

MDA approval of the Minnesota dicamba label and information regarding MN-specific requirements for mandatory applicator training have not yet been announced. The registrants report progress and anticipate a state approval of the label and mandatory registrant training requirements in mid-January.

Registrant training is available in 30 other states but is not currently available in Minnesota. Registrants release of their respective online training modules is targeted for the middle of January and webinar training events are being scheduled as early as Jan 20th but no training will be valid for the state of MN prior to MDA approvals of the label and the mandatory training program including MN-specific requirements.

BASF Information on training can be found at https://engeniastewardship.com/#/training.

Bayer link for the mandatory training options will be posted at the following site www.roundupreadyxtend.com  under the Training and Stewardship section  https://www.roundupreadyxtend.com/stewardship/Pages/default.aspx

Syngenta The training will be available at the following website: https://www.syngenta-us.com/herbicides/tavium-application-stewardship

Additional MDA Guidance on Cancelled Dicamba Products

Please find a question and answer guide from the MN Department of Agriculture here: https://www.mda.state.mn.us/sites/default/files/inline-files/MDA%20Dicamba%202020%20Guidance.pdf

Mandate Issued on Dicamba Court Ruling

In an Ag Retailer Association Alert issued earlier this morning, they mentioned that until the 9th Circuit publishes a Mandate to enforce its order in the dicamba case, that the labels for the three products were still in effect.

ARA has now received a copy of the Mandate from the Court. Given this development, ARA has now advised that the safest conclusion to draw is that the registrations have been vacated and the products are no longer labeled. There may still be some legal recourse available to EPA and the manufacturers, but ARA has advised ceasing applications of Xtendimax, Engenia and Fexapan until advised by the registrants that it is legal to do so.

ARA has not yet received guidance from EPA.

Bayer will be updating this site with information. (ARA)